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Endopeptidase-24.11 (EC 3.4.24.11) from pig kidney hydrolysed CCK-8 (sulphated) at two distinct sites: 
Asp-Tyr(SO,H)-Met-GlylTrp-Met-AsplPheNH,. Under initial conditions, the splitting of the Asp’- 
PhesNH, bond proceeded 4-times more rapidly than the Gly4-TrpS bond. Pig brain striatal synaptic mem- 
branes attacked this substrate at the same sites and this activity was inhibited by phosphoramidon. How- 
ever, other products were detected even in the presence of phosphoramidon. One of these products was 
identified as free tryptophan. Since their formation was inhibited by bestatin, one or more membrane 
aminopeptidases i also implicated in the degradation of CCK-8. 
Cholecystokinin (CCK-8) Endopeptidase-24.11 Aminopeptidase 
synaptic membrane 
Phosphoramidon Bestatin Pig brain 
1. INTRODUCTION 
The C-terminal fragment of cholecystokinin 
(CCK-8, Asp-Tyr-Met-Gly-Trp-Met-Asp-PheNHz) 
is present in brain as the Tyr2 sulphated form [l] 
and may well play a role as a neurotransmitter [2]. 
Hence, an understanding of its mode of inactiva- 
tion by synaptic membranes is important. Only 
one report of the degradation of CCK-8 by brain 
peptidases has appeared [3]. These authors 
solubilized a crude synaptosomal-mitochondrial 
pellet from rat brains with Triton X-100 and 
resolved, by DEAE-cellulose chromatography, 
several peaks of activity capable of degrading 
CCK-8. Peak I had properties similar to those we 
have described for endopeptidase-24.11 [4] which 
is present in the striatum of pig brain [5]. Incuba- 
tion of Peak I fractions with CCK-8 yielded two 
peptide products detected by the intrinsic 
fluorescence of the Trp residue. The main product 
was identified as Asp-Tyr(S03H)-Met-Gly-Trp, 
the other was not characterized. This observation 
implies that the principal site of cleavage by this 
enzyme preparation was at the Trp’-Met6 bond. 
However, in our survey [6] of neuropeptide 
degradation by endopeptidase-24.11, we did not 
encounter hydrolysis of an -X-Met- bond even 
though such a bond was present in two of the 
substrates examined (Tyr-Gly-Gly-Phe-Met-Arg 
and Tyr-Gly-Gly-Phe-Met-Arg-Phe). Here we 
have investigated the degradation of sulphated 
CCK-8 by purified endopeptidase-24.11 and report 
that the only bonds split were Gly4-Trp’ and 
Asp7-Phe*NH2. Pig striatal synaptic membranes 
hydrolysed the same bonds but additional activity, 
most probably representing one or more bestatin- 
sensitive aminopeptidases, was also responsible for 
the degradation of CCK-8. 
2. Experimental 
2.1. Peptides and inhibitors 
CCK-8 (sulphated and nonsulphated) and cap- 
topril (SQ14225; D-3-mercapto-2-methylpropano- 
yl-L-proline) were gifts from Squibb Institute for 
Medical Research, Princeton, NJ. Other CCK-8 
fragments and Phe-Met-Arg-PheNH2 were obtain- 
Published by Elsevier Science Publishers B. V. 
00145793/84/$3.00 0 1984 Federation of European Biochemical Societies 124 
Volume 175, number 1 FEBS LETTERS September 1984 
ed from Cambridge Research Biochemicals 
(Harston, Cambridge). Pentagastrin was supplied 
by ICI Pharmaceuticals (Macclesfield, Cheshire). 
Phenylalanylamide was from Sigma (London). 
The peptidyl dipeptidase A inhibitor MK422 (N- 
[(S)-1-carboxy-3-phenylpropyll-L-Ala-L-Pro) was 
provided by Merck, Sharp & Dohme, Hoddesdon, 
Herts. 
2.2. Membranes and enzyme preparations 
Synaptic membranes from pig striatum were 
prepared as in [5]. Endopeptidase-24.11 was 
purified from pig kidneys by immunoaffinity 
chromatography [7]. 
2.3. Hydrolysis of CCK-8 
Samples of synaptic membranes (14Opg protein) 
or endopeptidase-24.11 (20-200 ng) in 0.1 M 
Tris-HCl (pH 7.4) were incubated with 0.j mM 
CCK-8 for 30 min at 37°C (final volume 100 ~1). 
The reaction was stopped and the products analys- 
ed by high-performance liquid chromatography 
(HPLC) as described for substance P [5], except 
that each sample was monitored at two 
wavelengths, 214 and 280 nm. 
3. RESULTS 
3.1. Hydrolysis of CCK-8 by endopeptidase-24.1 I 
The peptide products demonstrated as A214 and 
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Fig. 1. Hydrolysis of CCK-8 by endopeptidase-24.11. 
The peptide products of CCK-8 hydrolysis were resolved 
by HPLC and were monitored at 214 nm (a) and 
280 nm (b). 
Table 1 
Products released by incubation of CCK-8 (sulphated) 
with endopeptidase-24.11 
Peak Retention Peptide identified Fragment 
no. time (min) of CCK-8 
1 3.52 Fa 8 
2 6.28 D-Y-M-G l-4 
3 7.90 W-M-D 5-7 
4a 11.06 W-M-D-Fa 5-8 
5 11.54 D-Y-M-G-W-M-D l-7 
6 13.80 D-Y-M-G-W-M-D-Fa CCK-8 
aPeak 4 was a minor one, inadequate in amount for 
amino acid analysis; its identity was predicted by co- 
elution with a marker peptide 
See section 2 for details. Data are from incubations 
achieving 60-90% degradation of CCK-8. The yields 
calculated from the analysis of each amino acid were 
zt20% of those required for the peptides shown. The 
presence of tryptophan (W) was inferred from the Azso 
value. 
Azse peaks are shown in fig. 1. Five A214 peaks were 
identified, 3 of which absorbed at 280 nm and, 
therefore, contained tryptophan. The identities of 
these peptides were established by amino acid 
analyses, shown in table 1. All the products so 
identified could be attributed to hydrolysis at two 
sites: 
Asp-Tyr(SOsH)-Met-GlyiTrp-Met-As&PheNHz 
The time course of hydrolysis was investigated. 
The formation of 3 peptides, Asp-Tyr(SOjH)-Met- 
Gly-Trp-Met-Asp (peak 5), Trp-Met-Asp (peak 3) 
and PheNHz (peak 1) is shown in fig.2. The 
relative rates of hydrolysis at the two sites can be 
assessed by the initial rates of formation of peak 5 
for the Asp’-Phe*NHz bond and peak 3 for the 
Gly4-Trp’ bond (see fig.2 inset). The former is 
produced 4-times faster. Peak 4 was not detectable 
under these conditions. 
Since the major site of cleavage of CCK-8 by 
endopeptidase-24.11 proved to be a rather unusual 
bond, we further investigated the ability of the en- 
zyme to release a C-terminal PheNH2 by using two 
other substrates, Phe-Met-Arg-PheNH2 and pen- 
tagastrin, Boc-PAla-Trp-Met-Asp-PheNH2. In 
both cases, release of the C-terminal PheNH2 was 
confirmed (not shown). 
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Fig.2. Time course of CCK-8 hydrolysis by 
endopeptidase-24.11. Three products were quantified: 
peak 1 by A214 using a standard (PheNH2); Peaks 3 and 
5 by Azsa using tryptophan as the standard. In the main 
figure hydrolysis was allowed to proceed to completion 
(200 ng of enzyme). In the inset figure the conditions 
were such (20 ng enzyme) that the initial rate of 
hydrolysis was linear for a 60 min period. l , Peak 1 
(PheNHz); n , peak 5 (D-Y-M-G-W-M-D); 0, peak 3 
(W-M-D). 
3.2. Hydrolysis of CCK-8 by synaptic membranes 
The HPLC elution patterns monitored at 214 
nm are shown in fig.3. In the first experiment 
(fig.3a), CCK-8 was incubated in the absence of in- 
hibitors. Peaks with identical retention times to 
peaks l-3 and 5 generated by endopeptidase-24.11 
(fig.1, table 1) were observed. In addition, two 
other peaks were seen and one of these was iden- 
tified as tryptophan (retention time, 6.56 min). 
Neither peak was seen when bestatin was present. 
When the incubation was repeated in the presence 
of 1OOpM bestatin and 1 ,uM phosphoramidon, to 
inhibit aminopeptidase and endopeptidase-24.11 
activities, virtually no hydrolysis was observed 
(fig. 3b). 
3.3. Effect of inhibitors on the hydrolysis of 
CCK-8 by synaptic membranes 
The results of a more detailed study of the effect 
of inhibitors are shown in table 2. Phosphor- 
amidon, which wholly abolished the hydrolysis of 
CCK-8 by endopeptidase-24.11 (not shown), was 
only partially effective with the synaptic mem- 
branes. Although the peptide products in peaks 
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Fig.3. Hydrolysis of CCK-8 by synaptic membranes. 
The products were analysed by HPLC, monitored at 214 
nm. (a) No inhibitors; (b) incubation in the presence of 
100 ,uM bestatin and 1 FM phosphoramidon. 
l-3 and 5 were very substantially inhibited, 
phosphoramidon had relatively little effect on pro- 
duct 1 a (not defined) and product 2a (tryptophan). 
Bestatin had no significant effect on peaks l-3 and 
5, but abolished the release of the tryptophan and 
product la. Combination of both inhibitors 
prevented detectable hydrolysis of CCK-8, as 
shown in fig.3b. Specific inhibitors of peptidyl 
dipeptidase A (EC 3.4.15.1, angiotensin-convert- 
ing enzyme), namely captopril and MK422, and a 
general inhibitor of serine peptidases, diisopropyl 
fluorophosphate, had no appreciable effect. 
4. DISCUSSION 
4.1. Specificity of endopeptidase-24. II 
Only two bonds in sulphated CCK-8, Asp’- 
Phe’NHz and Gly4-Trp’, were hydrolysed. The 
former was cleaved about 4-times faster than the 
latter. No peptides generated by an attack at the 
Trp’-Met6 bond were observed at either early or 
late stages in the degradation of the peptide. There 
is, therefore, a discrepancy between our results and 
those of authors in [3] regarding the site of attack. 
Different species, different regions of the brain 
and different degrees of purity of the enzyme may 
possibly have contributed to the discrepancy. But 
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Table 2 
The effect of inhibitors on the hydrolysis of CCK-8 (sulphated) by pig striatal synaptic 
membranes 
Peak Retention Peptide/amino Effect of inhibitors on peak area (control (no 
time (min) acid inhibitors) = 100 for each peak) 
Phosphor- Bestatin P Capto- MK422 DipF 
amidon + pril 
(P) (B) B 
la 3.22 n.d. 87 0 0 87 95 81 
1 3.52 Fa 0 91 0 90 94 91 
2 6.28 D-Y-M-G 0 94 0 93 93 103 
2a 6.56 W 43 8 0 95 95 99 
3 7.90 W-M-D 8.5 101 0 99 98 101 
5 11.54 D-Y-M-G-W-M-D 11 99 5 98 97 95 
The inhibitors were added at the start of the incubation period, except for diisopropyl 
fluorophosphate (DipF) which was preincubated with membranes for 30 min at 20°C. The 
concentrations were phosphoramidon, 1 pM; bestatin, 100 pM; captopril, 1 ,uM; MK422, 
1 pM; DipF, 100 ,uM. The numbered peaks correspond to those shown in fig. 1 and table 
1. In the absence of any inhibitors, 8% of the substrate was hydrolysed under the conditions 
used, to a specific activity of 1.0 nmol. min-’ . mg-’ protein (n.d., not defined) 
a more likely explanation is that the monitoring 
system used by these workers registered only 
tryptophan-containing peptides. Hence, the prin- 
cipal product (PheNHz) and the N-terminal tetra- 
peptide (Asp-Tyr(SOsH)-Met-Gly) would have 
escaped detection. Their main product might cor- 
respond to peak 5 (Asp-Tyr(SOsH)-Met-Gly-Trp- 
Met-Asp) but it is difficult to explain why the se- 
quence analysis stopped short of Met6-Asp’. Their 
minor product might be similar to our peak 3 (Trp- 
Met-Asp). In the 3 methionine-containing peptides 
that we have used as substrates for pig endopep- 
tidase-24.11 (CCK-8 and the two extended [Met] 
enkephalins), the -X-Met- bond has resisted 
hydrolysis. Furthermore, although PheNHz was 
rapidly released from CCK-8, MetNH2 was not a 
product from either substance P [5] or [Me?] 
enkephalinamide [6]. 
4.2. Identity of the synaptic membrane peptidases 
hydrolysing CCK-8 
Phosphoramidon is a specific inhibitor of 
endopeptidase-24.11 [8]. Our results agree with 
those of authors in [3] that the release of peptide 
products was effectively inhibited by this reagent. 
However, the formation by synaptic membranes of 
other products absorbing at 214 nm (peaks la, 2a, 
table 2) was only partially inhibited, because of the 
successive removal of N-terminal residues by 
bestatin-sensitive aminopeptidase action. One of 
these amino acids was identified as tryptophan. 
The other product which absorbed at 214 nm dif- 
fered in retention time from tyrosine and probably 
represents tyrosine sulphate. More tryptophan was 
produced when the endopeptidase was acting, 
since the hydrolysis of the Gly4-Trp’ bond exposed 
that residue to attack by aminopeptidase. The 
combination of phosphoramidon and bestatin was 
necessary to block all degradation of CCK-8. 
In these experiments, the relative contributions 
of endopeptidase-24.11 and aminopeptidase activi- 
ty in the degradation of CCK-8 were assessed by 
the disappearance of substrate. Endopeptidase ac- 
tivity in the striatal membranes appeared to ac- 
count for about 80% of the degradation. Since the 
removal of the C-terminal PheNHz residue, which 
is the main site of the endopeptidase attack, is 
known to inactivate CCK-8 [9], endopeptidase- 
24.11 may play a major role in its inactivation in 
vivo in brain regions such as striatum that are 
relatively enriched in the enzyme. The release of 
PheNH2 in two other natural peptides, gastrin and 
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Phe-Met-Arg-PheNHz may also be an important 
factor in their biological inactivation at cell 
surfaces. 
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